One more run to sell my last couple of million shares would be nice. 🤷🏼‍♂️

Still trades on grey and has trade activity as well as activity on social media. Strange as f@ck.

You laugh, but there has been more activity and $PTTN even has more of a presence on Twitter than it did. Don’t know if it’s someone trying to work on shell value or what?

You are obviously not looking at all the DD being posted or the raw data coming from the company. These are exciting times.

Bingo! I now truly believe these are the 2 that are having Regen and clan geeking out. The NR2F6 breaks down the wall of the solid tumors and the CAR-T therapy kills it.

Or could it be a conflict of interest to pay someone in shares for a non-bias report? ???????

He is not running a lab so why should he hire anyone? The IP scientific creating is already done. They need it tested and ready to head for clinicals. That is all done by a third party company like Chemdiv or currently ProMab Biotechnologies, Inc.

Three letters “KCL”! ???????

Why the spread between bud and ask this morning? ???????

Item 3.02. Unregistered Sales of Equity Securities
On
July
19, 2022 Regen
Biopharma,
Inc.
(the
"Company
issued 54.514,492
common
shares
("Shares") to Coventry Enterprises LLC in satisfaction
of $180,552 of convertible indebtedness. The principal
balance and accrued interest payable remaining on the
$1,500,000 promissory
note
issued
to
Coventry
Enterprises LLC are both $0 as of July 19,2022.
All the abovementioned securities were issued pursuant
to Section 4(a) (2) of the securities Act of 1933, as
amended (the "Act"). No underwriters were retained to
serve as placement agents for the sale. The securities
were sold directly through our management. No
commission or other consideration was paid in
connection with the sale of the securities. There was no
advertisement or general solicitation made in connection
with this Offer and Sale of securities.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
Dated: July 20, 2022
REGEN
BIOPHARMA, INC.
By: Is/ David Koos

I still keep going back to why would Chemdiv agree to accept 800k for the 1.2m they were owed but they REQUIRED $RGBP to remain listed.

Why would the company that knew the test results of RGBP products care if Regen stayed listed?

Come on people. This has 1 or 2 small runs a to clean up the last of the notes. Then news will drop and organic growth takes over. Patience pays!

Lilly did act. They chose a different company and it fell flat on their face. The past articles tell us that region was in the running and since what they chose fell on his face it’s possible that region could be in the running again.

Crazy to think there is still an institutional owner in PTTN.


IFP Advisors, Inc ownership in PTTN / Patten Energy Solutions Group, Inc.

2022-01-12 - IFP Advisors, Inc has filed a 13F-HR form disclosing ownership of 27,777 shares of Patten Energy Solutions Group, Inc. (US:PTTN) with total holdings valued at $1,000 USD as of 2021-12-31. IFP Advisors, Inc had filed a previous 13F-HR on 2021-10-06 disclosing 27,777 shares of Patten Energy Solutions Group, Inc. at a value of $1,000 USD. This represents a change in shares of 0.00 percent and a change in value of 0.00 percent during the quarter.

Other investors with positions similar to IFP Advisors, Inc include Fisher Asset Management, LLC , Summit Global Investments , and Arkadios Wealth Advisors .

Like???

What interesting news?

Amen!

Placement closed March 14,2022

The offering closed on March 14th!

How much cash on hand did RGBP show on the last report?

At the very least it’s due to known IT property in the patents and known trials for some of those known IT properties used in trial/pre-clinical trials. There is no doubt they have worth, it’s just a matter of time before it is recognized how much. JMO ???????

Hell yea! ????

14 mil share movement

Canary still needed to come to an agreement with Cornell so maybe they didn’t get the agreement they were supposed to. If that is the case Koos made the right call 100%.

To add to this line of thinking. RGBP is now located in the same office space as Zander Pharm who had a lab for testing and by Koos making the statement he was actively looking for a CSO & Landon of Canary just happened to be the CSO in the past maybe they are wanting to further the testing in house.

Quote:
The LOI is the ROADMAP to the Definitive Agreement. The LOI was probably negotiated over a period of several weeks and was probably in negotiations when RGBP provided a Scope of Work order to Biotech Research Group directing Biotech Research Group to perform an independent assessment of work conducted to date on behalf of the Company by the Company’s Contract Research Organization in order to assist the Company in determining what would be the most efficient actions to undertake in order to commercialize the Company’s NR2F6 intellectual property as well as assist the Company with regulatory strategy with regard to the Company’s NR2F6 intellectual property .


Done some research in regard to the SCOPE OF WORK, this was not a value DETERMINATION report. This was to determine where RGBP WAS IN THE TESTING STAGE OF SCIENTIFIC PROCEDURES. Such evaluation can determine if they missed a procedure step and if any steps need to be repeated.

This is significant that KOOS had decided at this time to have all lab work verified, IMHO from my reading on the SOW (scope of work) ORDER evaluation process.

So to move to this process says Koos and his lab work procedures says they think there close. NOW IS NOT THE TIME TO SELL....HOLD

It has to do with the specific spike protein with the Covid virus but thanks for looking out for us all.

Why leave and come back? Well you should follow the IP deals and from where and to who they are with and then follow the people connected to Koos and see where they are and who they are connected to and ask yourself how could all the people and pieces be mutually beneficial to each other. ???????

Why would you be worried about the licensing deal with ONPH? The only thing it does it change it from exclusive to nonexclusive meaning he can license it out to other companies. What has already been paid by ONPH is NONREFUNDABLE.

Valuation for collateral?

Empty shell that Remo gutted himself. Sad really.

More like the dumpster!

It could very well be to those involved with ETNI. They paid $350,000 for a shell of a company for a reason. ???????

Caven was the CFO. Now he is https://saguarocapitalpartners.com/
But the address on the last updated patent and Saguaro are the same. Maybe the source for the $50,000,000

He’ll get that from his old buddy Todd Caven who use to be the CFO but now https://saguarocapitalpartners.com/
Compare the address of the last patent update with that of Saguaro.

LANDON

LOL, I had a small opportunity to look back on this feed. Sorry. LMAO

Does any of you think this Company or it’s parent company has anything to do with RGBP & it’s recent urgency to get current and secure patents etc?

I believe CSC is the registered Agent for Canary.

What makes you think they were started a few days ago?

Hmmmm now there might be a buyout but the buyer wouldn’t pay more than .02. Complete perspective change on your part. Welcome to the optimistic side. LOL